- Home
- Products
Tivdak (tisotumab vedotin-tftv)
Tivdak (tisotumab vedotin-tftv)
Medicine Name: Tivdak
Generic Name: Tisotumab Vedotin-tftv
Dosage Form & Strength: Injection – 40 mg (lyophilized powder in single-dose vial)
Manufactured By: Seagen Inc.
Tivdak is a tissue factor-directed antibody-drug conjugate (ADC) approved for the treatment of:
- Adult patients with recurrent or metastatic cervical cancer whose disease has progressed on or after chemotherapy
Recommended Dosage:
- 2 mg/kg (max 200 mg) administered as a 30-minute IV infusion every 3 weeks
- Continue until disease progression or unacceptable toxicity
- Do not administer as a bolus or mix with other medications
Ocular Toxicity: Conduct ophthalmic exams (visual acuity, slit-lamp) before each dose. Ocular reactions may require dose delays or discontinuation.
Peripheral Neuropathy: Monitor for numbness, tingling, pain, or weakness. Adjust dosage based on severity.
Hemorrhage Risk: Monitor for signs of bleeding, especially CNS or pulmonary hemorrhage. Permanently discontinue if confirmed.
Pneumonitis: Life-threatening cases reported. Monitor for cough, hypoxia, dyspnea, and discontinue in severe cases.
Fetal Harm: Tivdak can cause fetal harm. Use effective contraception during treatment and for 2 months after the last dose.
Lactation: Avoid breastfeeding during treatment and for 2 months post-treatment.
Required Documents to Import Tivdak to India:
- Valid prescription from a certified doctor
- Supporting diagnostic reports
- Government-issued photo ID of the patient
Order Confirmation:
Initiated only after receipt of all documentation and import permit, if required.
Availability in India & Abroad:
Available in Mumbai, Delhi, Chennai, Kolkata, Hyderabad, Ahmedabad, Bangalore, Pune, and other Indian cities. Export available under the Named Patient Program.
To Order or Enquire Price:
- 📞 Call/WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Tivdak from trusted international suppliers in the USA, Europe, Canada, and Australia. Orders are:
- Verified by licensed pharmacists
- Shipped from the Ambernath Fulfillment Center, Thane District
- Compliant with legal & cold-chain requirements
What is the generic name of Tivdak®?
Tisotumab Vedotin-tftv
Who manufactures Tivdak®?
Seagen Inc.
Is Tivdak® FDA approved?
Yes, approved on September 20, 2021
What is Tivdak® used for?
Recurrent/metastatic cervical cancer post-chemotherapy
What form is Tivdak® supplied in?
40 mg lyophilized powder for reconstitution (IV infusion)
What are common side effects?
Rash, fatigue, dry eyes, nausea, diarrhea, anemia, hair loss, epistaxis, reduced blood counts
How should Tivdak® be stored?
Refrigerate at 2°C to 8°C in original carton. Do not freeze or shake
Can I buy Tivdak® online in India?
Yes, through Global Rare Meds, a WHO-GDP & ISO-certified platform
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
